Patents by Inventor Ian Hardy

Ian Hardy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12036241
    Abstract: Compounds that either produce a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies, such as those providing improvements in one or more therapeutic outcomes, are provided.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: July 16, 2024
    Assignees: FATE THERAPEUTICS, INC., JUNO THERAPEUTICS, INC.
    Inventors: Jonathan Rosen, Eigen Peralta, Ian Hardy, Betsy D. Rezner, Christian Maine, Daniel Shoemaker, David Robbins, Lucas Thompson
  • Patent number: 11932870
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: March 19, 2024
    Inventors: Jonathan Rosen, Betsy Denise Rezner, Ian Hardy, Eigen Peralta
  • Publication number: 20230298739
    Abstract: A system comprises a plurality of first computing devices, wherein each first computing device is wearable by a user or is affixed to an asset within an environment and configured to generate and transmit a message; and a plurality of second computing devices installed within the environment, wherein a portion of the plurality of second computing devices are configured to detect at least one of the plurality of first computing devices, receive messages transmitted by a detected first computing device, and timestamp the messages before transmitting the messages to a computing server system. The computing server system is configured to determine at least a location of the detected first computing device based at least upon the messages received from the portion of the plurality of second computing devices.
    Type: Application
    Filed: August 5, 2021
    Publication date: September 21, 2023
    Applicant: Geonavo Positioning Systems, Inc.
    Inventors: Malcolm Williams, Stewart Ian Hardie, Ioan Romulus Curticapean, Benjamin Griffen Ryan Hudson
  • Patent number: 11413309
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: August 16, 2022
    Assignee: FATE THERAPEUTICS, INC.
    Inventors: Jonathan Rosen, Betsy Rezner, Bahram Valamehr, Ryan Bjordahl, Eigen Peralta, Ian Hardy
  • Patent number: 11091546
    Abstract: Disclosed herein are chimeric antigen receptor effector cells (CAR-ECs) and CAR-EC switches. The switchable CAR-ECs are generally T cells. The one or more chimeric antigen receptors may recognize a peptidic antigen on the CAR-EC switch. The CAR-ECs and switches may be used for the treatment of a condition in a subject in need thereof.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: August 17, 2021
    Assignee: The Scripps Research Institute
    Inventors: Travis Young, David T. Rodgers, Ian Hardy, Chanhyuk Kim, Peter G. Schultz, Eric Hampton, Eduardo Laborda, Leonard Presta
  • Publication number: 20200181573
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Application
    Filed: December 4, 2017
    Publication date: June 11, 2020
    Inventors: Jonathan Rosen, Betsy Denise Rezner, Ian Hardy, Eigen Peralta
  • Publication number: 20200179451
    Abstract: Compounds that either produce a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies, such as those providing improvements in one or more therapeutic outcomes, are provided.
    Type: Application
    Filed: July 19, 2018
    Publication date: June 11, 2020
    Inventors: Jonathan Rosen, Eigen Peralta, Ian Hardy, Betsy D. Rezner, Christian Maine, Daniel Shoemaker, David Robbins, Lucas Thompson
  • Publication number: 20190282618
    Abstract: Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
    Type: Application
    Filed: January 20, 2017
    Publication date: September 19, 2019
    Inventors: Jonathan Rosen, Betsy Rezner, Bahram Valamehr, Ryan Bjordahl, Eigen Peralta, Ian Hardy
  • Publication number: 20080139604
    Abstract: A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate flushing that may otherwise occur.
    Type: Application
    Filed: February 15, 2006
    Publication date: June 12, 2008
    Inventors: Shaun Fitzpatrick, Christian Seiler, Ian Hardy, M. Gerard Waters, Eseng Lai
  • Patent number: 5541081
    Abstract: Methods and compositions for assessing the quality of an oocyte or pre-implantation embryo are provided. The methods involve comparing the NADH fluorescence of the oocyte or embryo in a control medium to the NADH fluorescence after the oocyte or embryo has been contacted with an essential nutrient.
    Type: Grant
    Filed: March 22, 1994
    Date of Patent: July 30, 1996
    Assignees: President and Fellows of Harvard College, Brigham and Women's Hospital, Inc.
    Inventors: R. Ian Hardy, David E. Golan, John D. Biggers
  • Patent number: 4901275
    Abstract: A unit for providing an interface between analog input signals and a digital data processing system bus includes a plurality of analog input channels, sample-and-hold circuits, and an analog-to-digital converter. An optical isolation circuit couples the output of the analog-to-digital converter to a dual-port RAM. The gain of each analog input channel is programmable, as is the address of each input channel in the RAM. Thus the channels can be read in any desired order, and different input voltage ranges can be programmed for each channel. The RAM can be read by an external data processing system via a digital system bus.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: February 13, 1990
    Assignee: Burr-Brown Limited
    Inventors: Ian Hardie, David Vine